Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...

Ascletis Pharma has posted phase 2 data on its ultra-long-acting GLP-1 receptor analog, generating early evidence that the formulation may support quarterly dosing as a maintenance therapy. Eli ...

Not all muscle cars are created equal. However, despite various renditions, muscle cars are, for the most part, power-laden, performance machines often characterized by vocal soundtracks. As far as ...

A Metropolitan Transportation Authority rendering shows a conceptual interior of a future Second Avenue Subway station in Harlem, illustrating platform circulation, train clearances and passenger flow ...

OASIS+ is a suite of six multiple-award, indefinite-delivery/indefinite-quantity contracts with a five-year base period and a five-year option term. The contract ...

The next year's just around the corner, and for US-based enthusiasts, it comes with the possibility to legally import one of these awesome modern classics thanks to the 25-Year Import Rule. Follow us: ...

Success rates in phase II and phase III clinical trials are recognized as two of the most powerful drivers of overall efficiency in drug development (Nat. Rev. Drug Discov. 23, 656–657; 2024). With ...

The new year is nearly here, and with the arrival of 2026 comes a whole slew of newly legal imports. Thanks to the long-standing law stating that models not originally produced for the U.S. market are ...

Kelluu produces hydrogen-powered airships, providing aerial sensing capability as a service. Above, testing during NATO ‘REPMUS 2025'. (NATO DIANA) NATO's Defence Innovation Accelerator for the North ...

The General Services Administration has launched the second phase of the One Acquisition Solution for Integrated Services Plus, or OASIS+, contract program, adding five new service domains as part of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel GLP-1 and amylin receptor agonist reduced HbA1c ...